Recruiting studies: Inborn Errors Of Immunity

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
Phase 4 · 12 location(s) · BioMarin Pharmaceutical · NCT07477691 Identification of Clinical, Genetic and Immunological Factors Involved in the Development of Severe Bacterial Infections
NA · 6 location(s) · Nantes University Hospital · NCT07111793 PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inb
Phase 2 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT06199427 NIAID Centralized Sequencing Protocol
Phase N/A · 2 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT03206099 The Interplay Between Inborn Error of Immunity and Blood Disorders: Unravelling Immune Defects Behind Common Haematologi
NA · 7 location(s) · Meyer Children's Hospital IRCCS · NCT06857604 Immunodysregulation As an Expression of Underlying Inborn Errors of Immunity: Implementation of Diagnostics and Manageme
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06773546 Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06169150 Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00001244 Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT04339777 The NIH MINI Study: Metabolism, Infection, and Immunity in Inborn Errors of Metabolism
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT01780168 A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
Phase N/A · 11 location(s) · BioMarin Pharmaceutical · NCT06305234

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.